AR087209A2 - Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico - Google Patents
Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilicoInfo
- Publication number
- AR087209A2 AR087209A2 ARP120102582A ARP120102582A AR087209A2 AR 087209 A2 AR087209 A2 AR 087209A2 AR P120102582 A ARP120102582 A AR P120102582A AR P120102582 A ARP120102582 A AR P120102582A AR 087209 A2 AR087209 A2 AR 087209A2
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- bencimidazol
- preparation
- bifenil
- ilmetil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicación 1: Procedimiento para la preparación de telmisartan, caracterizado porque (a) 2-n-propil-4-metil-6-(1’-metilbencimidazol-2’-il)-bencimidazol de fórmula (1) se hace reaccionar con un compuesto de la fórmula general (2) en la cual Z representa un grupo lábil, y el compuesto así obtenido, en caso deseado, se somete a una elaboración, (b) el grupo ciano del compuesto, así obtenido, 2-ciano-4’-[2’’-n-propil-4’’-metil-6’’-(1’’’-metilbencimidazol-2’’’-il)-bencimidazol-1’’-il-metil]bifenilo de fórmula (3) se transforma a continuación por hidrólisis en la función ácido, y el telmisartan, así obtenido, se transforma durante la elaboración, en caso deseado, en el hidrocloruro.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10314702A DE10314702A1 (de) | 2003-03-31 | 2003-03-31 | Verfahren zur Herstellung von Telmisartan |
Publications (1)
Publication Number | Publication Date |
---|---|
AR087209A2 true AR087209A2 (es) | 2014-02-26 |
Family
ID=33016100
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101066A AR043794A1 (es) | 2003-03-31 | 2004-03-31 | Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico |
ARP120102582A AR087209A2 (es) | 2003-03-31 | 2012-07-17 | Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101066A AR043794A1 (es) | 2003-03-31 | 2004-03-31 | Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico |
Country Status (26)
Country | Link |
---|---|
US (2) | US7193089B2 (es) |
EP (2) | EP2322511B1 (es) |
JP (1) | JP5160740B2 (es) |
KR (1) | KR101096499B1 (es) |
CN (1) | CN100418953C (es) |
AR (2) | AR043794A1 (es) |
AT (1) | ATE515500T1 (es) |
AU (1) | AU2004226239B2 (es) |
BR (1) | BRPI0408861A (es) |
CA (1) | CA2520714C (es) |
CL (1) | CL2004000687A1 (es) |
CY (2) | CY1112020T1 (es) |
DE (1) | DE10314702A1 (es) |
DK (2) | DK2322511T3 (es) |
ES (2) | ES2432647T3 (es) |
IL (1) | IL171145A (es) |
MX (1) | MXPA05009529A (es) |
NZ (1) | NZ543244A (es) |
PE (1) | PE20050390A1 (es) |
PL (2) | PL2322511T3 (es) |
PT (2) | PT2322511E (es) |
RU (1) | RU2430092C2 (es) |
SI (2) | SI1611108T1 (es) |
TW (1) | TWI335916B (es) |
UY (1) | UY28246A1 (es) |
WO (1) | WO2004087676A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10314702A1 (de) * | 2003-03-31 | 2004-10-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von Telmisartan |
GB2414019A (en) * | 2004-05-11 | 2005-11-16 | Cipla Ltd | One-step preparation of telmisartan by condensation and hydrolysis |
DE102004045796A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
KR20070061583A (ko) * | 2004-10-15 | 2007-06-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 텔미사르탄의 제조 방법 |
US7943781B2 (en) | 2004-10-18 | 2011-05-17 | Dr. Reddy's Laboratories Limited | Process for preparing telmisartan |
EP1871764A1 (en) * | 2005-04-01 | 2008-01-02 | LEK Pharmaceuticals D.D. | A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
ITMI20050801A1 (it) * | 2005-05-03 | 2006-11-04 | Dipharma Spa | Procedimento per la preparazione di telmisartan |
WO2006136916A2 (en) * | 2005-06-20 | 2006-12-28 | Glenmark Pharmaceuticals Limited | Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same |
US20060264491A1 (en) * | 2006-06-08 | 2006-11-23 | Chemagis Ltd. | Telmisartan production process |
CN101172968B (zh) * | 2006-11-01 | 2010-05-12 | 浙江天宇药业有限公司 | 2-正丙基-4甲基-6-(甲基苯并咪唑-2-基)苯并咪唑盐及其制备方法 |
CN101743228B (zh) * | 2007-07-03 | 2014-01-29 | 新梅斯托克尔卡托瓦纳兹德拉韦尔公司 | 替米沙坦的制备方法 |
CZ302272B6 (cs) | 2007-07-09 | 2011-01-19 | Zentiva, A. S. | Zpusob výroby 4´-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-karboxylové kyseliny (telmisartanu) |
WO2009116089A2 (en) * | 2008-03-14 | 2009-09-24 | Ipca Laboratories Limited | Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid. |
EP2103588A1 (en) * | 2008-03-20 | 2009-09-23 | Lek Pharmaceuticals D.D. | 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists |
US8410285B2 (en) | 2008-03-20 | 2013-04-02 | Lek Pharmaceuticals D.D. | 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists |
EP2103609A1 (en) * | 2008-03-20 | 2009-09-23 | Lek Pharmaceuticals D.D. | Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
EP2123648A1 (en) | 2008-05-20 | 2009-11-25 | Chemo Ibérica, S.A. | A process for the preparation of Telmisartan. |
EP2149566A1 (en) | 2008-07-15 | 2010-02-03 | Chemo Ibérica, S.A. | A process for the preparation of telmisartan |
SI2443094T1 (sl) | 2009-06-19 | 2013-08-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek za pripravo telmisartana |
EP2277866A1 (en) * | 2009-06-22 | 2011-01-26 | Inke, S.A. | Process for preparing telmisartan |
EP2305650A1 (en) | 2009-09-21 | 2011-04-06 | Chemo Ibérica, S.A. | Novel process for the preparation of telmisartan |
EA025946B1 (ru) | 2010-10-27 | 2017-02-28 | Крка, Товарна Здравил, Д. Д., Ново Место | Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин |
CN102267949A (zh) * | 2011-06-14 | 2011-12-07 | 张长利 | 替米沙坦制备新工艺 |
WO2014027280A1 (en) | 2012-08-14 | 2014-02-20 | U Amarnath Amarnath | One pot process for the preparation of telmisartan |
CN103787982A (zh) * | 2012-10-31 | 2014-05-14 | 上海特化医药科技有限公司 | 制备替米沙坦的方法及其中间体 |
CN104557724B (zh) * | 2014-11-17 | 2017-01-11 | 江苏中邦制药有限公司 | 替米沙坦不定形晶型及其制备方法 |
CN105130905B (zh) * | 2015-09-17 | 2017-09-08 | 浙江金立源药业有限公司 | 一种替米沙坦的合成方法 |
CN109912512B (zh) * | 2017-12-13 | 2023-05-30 | 上海科胜药物研发有限公司 | 一种新的替米沙坦杂质化合物及其制备方法和用途 |
CN112251770B (zh) * | 2020-10-14 | 2021-07-27 | 湖南大学 | 一种抗高血压药替米沙坦中间体电化学制备新方法 |
CN113307775B (zh) * | 2021-04-16 | 2022-04-22 | 河北戴桥医药科技有限公司 | 一种替米沙坦的制备方法 |
WO2023204729A1 (ru) * | 2022-04-19 | 2023-10-26 | Общество с ограниченной ответственностью "Гелеспон" | Фармацевтические композиции на основе новой субстанции 4-[2-(1н-имидазол-4-ил)-этилкарбамоил]-бутановой кислоты и способ получения субстанции |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4023369A1 (de) * | 1990-07-23 | 1992-01-30 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
RU1836357C (ru) * | 1990-07-23 | 1993-08-23 | Др.Карл Томэ ГмбХ | Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами |
DE4103492A1 (de) * | 1991-02-06 | 1992-10-08 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
SI9210098B (sl) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
US5591762A (en) | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
DE19901921C2 (de) * | 1999-01-19 | 2001-01-04 | Boehringer Ingelheim Pharma | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
US6358986B1 (en) | 1999-01-19 | 2002-03-19 | Boehringer Ingelheim Pharma Kg | Polymorphs of telmisartan |
US6737432B2 (en) | 2001-10-31 | 2004-05-18 | Boehringer Ingelheim Pharma Kg | Crystalline form of telmisartan sodium |
DE10314702A1 (de) * | 2003-03-31 | 2004-10-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von Telmisartan |
-
2003
- 2003-03-31 DE DE10314702A patent/DE10314702A1/de not_active Withdrawn
-
2004
- 2004-03-17 US US10/802,142 patent/US7193089B2/en active Active
- 2004-03-26 NZ NZ543244A patent/NZ543244A/en not_active IP Right Cessation
- 2004-03-26 JP JP2005518684A patent/JP5160740B2/ja not_active Expired - Lifetime
- 2004-03-26 DK DK10192561.8T patent/DK2322511T3/da active
- 2004-03-26 ES ES10192561T patent/ES2432647T3/es not_active Expired - Lifetime
- 2004-03-26 EP EP10192561.8A patent/EP2322511B1/de not_active Expired - Lifetime
- 2004-03-26 KR KR1020057018333A patent/KR101096499B1/ko active IP Right Grant
- 2004-03-26 AU AU2004226239A patent/AU2004226239B2/en not_active Expired
- 2004-03-26 AT AT04739071T patent/ATE515500T1/de active
- 2004-03-26 CA CA2520714A patent/CA2520714C/en not_active Expired - Fee Related
- 2004-03-26 PT PT101925618T patent/PT2322511E/pt unknown
- 2004-03-26 SI SI200431740T patent/SI1611108T1/sl unknown
- 2004-03-26 CN CNB2004800087194A patent/CN100418953C/zh not_active Expired - Lifetime
- 2004-03-26 BR BRPI0408861-1A patent/BRPI0408861A/pt not_active Application Discontinuation
- 2004-03-26 PL PL10192561T patent/PL2322511T3/pl unknown
- 2004-03-26 PL PL04739071T patent/PL1611108T3/pl unknown
- 2004-03-26 SI SI200432083T patent/SI2322511T1/sl unknown
- 2004-03-26 DK DK04739071.1T patent/DK1611108T3/da active
- 2004-03-26 PT PT04739071T patent/PT1611108E/pt unknown
- 2004-03-26 MX MXPA05009529A patent/MXPA05009529A/es active IP Right Grant
- 2004-03-26 EP EP04739071A patent/EP1611108B1/de not_active Expired - Lifetime
- 2004-03-26 WO PCT/EP2004/003217 patent/WO2004087676A1/de active Application Filing
- 2004-03-26 RU RU2005133479/04A patent/RU2430092C2/ru active
- 2004-03-26 ES ES04739071T patent/ES2369081T3/es not_active Expired - Lifetime
- 2004-03-29 UY UY28246A patent/UY28246A1/es not_active Application Discontinuation
- 2004-03-29 TW TW093108537A patent/TWI335916B/zh not_active IP Right Cessation
- 2004-03-29 PE PE2004000331A patent/PE20050390A1/es not_active Application Discontinuation
- 2004-03-30 CL CL200400687A patent/CL2004000687A1/es unknown
- 2004-03-31 AR ARP040101066A patent/AR043794A1/es active IP Right Grant
-
2005
- 2005-09-28 IL IL171145A patent/IL171145A/en active IP Right Grant
-
2011
- 2011-09-28 CY CY20111100938T patent/CY1112020T1/el unknown
-
2012
- 2012-07-17 AR ARP120102582A patent/AR087209A2/es unknown
-
2013
- 2013-01-25 US US13/750,551 patent/US8993778B2/en active Active
- 2013-10-09 CY CY20131100879T patent/CY1115156T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR087209A2 (es) | Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico | |
AR030947A1 (es) | Guanidinas de acido cinamico substituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como un medicamento que las contiene | |
PE20091582A1 (es) | Procedimiento para la preparacion de dihidropteridinonas | |
NZ600516A (en) | Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance | |
HK1073841A1 (en) | Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist | |
BRPI0516735B8 (pt) | métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937) | |
SV2004001373A (es) | Inhibidores de pde9 para tratamiento de transtornos cardiovasculares. ref. pcs22051 | |
DE60233420D1 (de) | Fumagillolderivate und verfahren zu deren herstellung | |
CL2009001198A1 (es) | Metodo para cuantificar una pluralidad de objetos rodantes sobre una correa transportadora, que comprende suministrar la pluralidad de objetos rodantes a una primera velocidad horizontal, operar la correa transportadora a una segunda velocidad horizontal, y cuantificar la pluralidad de objetos rodantes sobre la correa transportadora a una segunda velocidad horizontal; metodo para reducir el agrupamiento; ensamble. | |
GT200400165A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
UY25980A1 (es) | Polimorfos de telmisartan | |
BR112012013316A2 (pt) | aditivo para agentes de ligação mineral tendo potencial reduzido de descoloração marrom | |
AR050709A1 (es) | Metodo para preparar irbesartan e intermediarios del mismo | |
UY32243A (es) | Proceso para la fabricacion de bromuros de 3-piridilmetil amonio sustituidos | |
BRPI0509988A (pt) | processo para preparar ácido acrìlico por oxidação parcial heterogeneamente catalisada de pelo menos um composto precursor de hidrocarboneto c3 | |
ITMI20022410A1 (it) | Procedimento per la nitrazione di alcandioli. | |
BRPI0506690A (pt) | processo para a preparação de 1,3-butileno glicol | |
PE20070809A1 (es) | Composicion veterinaria que comprende closantel | |
AR051991A1 (es) | Procedimiento para la preparacion de anilinas | |
AR047122A1 (es) | Isomerizacion de compuestos de semicarbazona | |
PE20060951A1 (es) | Proceso sintetico para la preparacion de compuestos aromaticos biciclicos | |
ECSP034920A (es) | Proceso para la preparacion de derivados de ciclohexanol | |
EA200201233A1 (ru) | Способ получения бифенильных соединений | |
AR042194A1 (es) | Metodo para preparar inhibidores de fosfodiesterasa - 4 | |
AR033772A1 (es) | Compuestos de 3-fenil-3,7-diazabiciclo[3,3,1]nonanto, asi como procedimientos para su preparacion y medicamentos que contienen estos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |